Testing effectiveness (Phase 2)Study completedNCT00321321
What this trial is testing
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
Who this might be right for
Diabetes Mellitus, Type 2
University Hospital, Gentofte, Copenhagen 12